InsidersTradesSigma
Follow the 바이오스마트 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 바이오스마트 has published 8 public disclosures. The latest transaction was disclosed on 26 August 2022 (Purchase). Among the most active insiders: 박혜린. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
8 of 8 declarations
BioSmart 是一家在XKRX市场上市的医疗保健和制药领域的公司。它专注于开发创新解决方案以增进人类健康。